Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Defying gravity

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Dec 15, 2022 1:19pm

114 Views

Post# 35173714

RE:RE:RE:Defying gravity

Lesalpes29 wrote:
TitanBrawler wrote: The only thing that's moving this pos is the pumpers.
Do you really think institutionals are looking at this pos.
There not.

People are getting played by professional pumpers.

It's so obvious.
One pumper in particular is spewing out information gathered by other
Oncolytic Biotech companies.

PRetty good results is helping to hold the SP today. Big red day but bus not that much. Good results will continue to show up and the SP is following up up. Go to .... le branleur!